Erratum to “Slender Sheath/Guiding Catheter Combination vs. Sheathless Guiding Catheter for Acute Coronary Syndrome: A Propensity-Matched Analysis of the Two Devices”
Table 4
Periprocedural access-site complications.
Variables
Total population
Propensity-matched population
Glidesheath n = 397
Sheathless n = 711
OR (95% CI)
Glidesheath n = 364
Sheathless n = 364
OR (95% CI)
RAD at 30 days, mm
2.0 (1.8–2.3)
2.1 (1.8–2.4)
0.15
2.0 (1.8–2.3)
2.1 (1.8–2.4)
0.06
End-procedural ACT, s
273 (231–312)
301 (250–376)
<0.001
273 (229–310)
289 (250–372)
<0.001
RAO at 30 days, n (%)
6 (1.5)
25 (3.5)
0.43 (0.18–1.04)
0.058
5 (1.4)
15 (4.1)
0.33 (0.12–0.91)
0.039
Severe radial spasm, n (%)
9 (2.3)
11 (1.6)
1.46 (0.61–3.49)
0.48
5 (1.4)
7 (1.9)
0.71 (0.23–2.22)
0.58
Access-site major bleeding within 30 days
BARC type 3 or 5, n (%)
5 (1.3)
9 (1.3)
0.99 (0.34–2.95)
1.00
5 (1.4)
6 (1.6)
0.83 (0.26–2.71)
1.00
BARC type 3, n (%)
5 (1.3)
9 (1.3)
0.99 (0.34–2.95)
1.00
5 (1.4)
6 (1.6)
0.83 (0.26–2.71)
1.00
BARC type 5, n (%)
0 (0)
0 (0)
n/a
n/a
0 (0)
0 (0)
n/a
n/a
Data are presented as median (interquartile range) or n (%), unless otherwise indicated. “Glidesheath” denotes 7-Fr Glidesheath slender/7-Fr guiding catheter combination group, and “Sheathless” denotes 7.5-Fr sheathless guiding catheter group. The asterisk denotes a statistically significant difference between the two groups. ACT; activated clotting time; BARC, bleeding academic research consortium; CI, confidence interval; n/a, not applicable; OR, odds ratio; RAD, radial artery diameter; RAO, radial artery occlusion.
